Mole Removal / Naevus Excision | Additional diagnosis and pathology questions

These changes matter because some moles can be melanoma or dysplastic lesions. ABCDE criteria—asymmetry, border irregularity, colour variation, diameter greater than 6 mm, and evolution—are red flags, and a new tender pink spot can also occur in fair skin. Pain, itching, inflammation, bleeding, crusting, or a new mark that does not settle within weeks also warrant assessment. If malignancy is suspected, shave or punch removal is not appropriate; complete excision with histopathology is needed. A clinician should consider biopsy or expedited referral for any lesion meeting these criteria. Cosmetic removal should wait until assessment is complete. Dr. Vishal Purohit can explain relevant options during consultation. No specific method or outcome is implied.

The decision to biopsy should combine clinical and dermoscopic examination of the lesion and surrounding lesions with your history of change, symptoms, and personal and family history of skin cancer and other relevant information. Dermoscopy improves diagnostic accuracy; in expert hands sensitivity may reach about 89 percent and can reduce unnecessary biopsies. In people with many moles, comparing a lesion with your usual “signature” pattern helps spot “ugly duckling” lesions. If a lesion looks benign, reassurance and follow-up may suffice; if suspicious, biopsy or expert referral is considered. The definitive diagnosis remains histopathology. Dermoscopy can also help distinguish pigmented basal cell carcinoma from melanoma. It supports, but does not replace, careful clinical judgment and histopathology.

For pigmented lesions with high suspicion, the diagnosis depends on seeing the full architecture and range of cell changes. Excisional biopsy provides the most complete specimen and reduces the chance of missing important features or leaving positive margins. Superficial shave, laser or diathermocoagulation should be avoided because they do not allow accurate staging and can delay diagnosis. Partial biopsy may be considered for large lesions or difficult areas such as the face, eye, nose or ear. Any excisional biopsy should be planned so its orientation and closure can be incorporated into a later wider excision if needed. Complete removal also lowers recurrence risk; recurrent nevi can look atypical and cause confusion.

Laser excision uses the laser like a scalpel to remove the whole lesion, while laser ablation destroys only surface tissue. Ablation is not routinely recommended because tissue is not excised for histopathological examination and the most abnormal basal epithelium may remain. Any suspicion of dysplastic change warrants excision biopsy with histopathological assessment. Shave excision and punch techniques are not appropriate when malignancy is suspected. Complete lesion excision can reduce malignant transformation at the original site and may identify unexpected early invasive squamous cell carcinoma histopathologically at an otherwise clinically undetectable stage in some cases. Laser treatment for melanocytic nevi has variable response and possible complications.

Histopathology confirms the diagnosis and can identify dysplasia or melanoma-related features. The request form should include your identity, surgery date, procedure type, clinical details, location and suspected diagnosis, with clear instructions on where to send the report. It also records margins and other features that guide whether further treatment or referral is needed. The pathologist may cut deeper levels, use special stains, or request immunohistochemistry if the first sections are unclear; if these extra investigations cause undue delay, a preliminary report should be issued. For melanocytic lesions, complete excision with free margins is preferred, and severe dysplasia can be interpreted differently by pathologists, so review may be needed.

Mole removal is usually followed by pathology testing, because a lesion that looked harmless can occasionally prove cancerous. If squamous cell carcinoma is found, management has two parts: treating the lesion itself and checking the rest of the skin for other non-melanoma skin cancers, with all patients discussed by the multidisciplinary skin cancer team. For melanoma, surgery to remove the mole is the main treatment, and early detection is generally curative. Destructive treatments should not be used before diagnosis is confirmed. Even when cancer is found, the outlook can be good, and a specialist decides whether further surgery, radiotherapy or careful observation is needed.

The method depends on type, size, location and depth. An acquired melanocytic nevus should be removed completely to reduce recurrence and pseudomelanoma risk, with minimal damage to surrounding skin and an aesthetically acceptable scar. Radiofrequency is indicated for lesions around eyes, nose and mouth, while suspected dysplastic change warrants excision biopsy and histopathology. For eyelid lesions, tissue conservation matters because wide resection can affect eye protection and moisture; reconstruction may be needed after larger defects. Extensive preoperative workup is usually not required; blood tests may rule out diabetes and bleeding disorders, and active infection or uncontrolled diabetes can delay treatment. Radiofrequency is contraindicated with cardiac disease, pacemakers or metallic prosthesis.

Shave excision removes the visible mole, but recurrence is known, especially if deeper nevus cells remain. An acquired melanocytic nevus should be removed completely to reduce recurrence and pseudomelanoma risk. The method depends on the mole’s type, size, location and anticipated depth, with minimal damage to surrounding skin and an aesthetically acceptable scar. Recurrences are known after shave and radiofrequency excisions. If regrowth appears, the recurrent mole may be excised by the same method but cut a bit deeper, so a shallow scar can remain. Any suspicion of dysplastic change warrants excision biopsy with histopathological assessment. Regular follow-up visits help detect regrowth early. After radiofrequency shave procedures, follow-up every two weeks for at least two months is described.

Shave excision can leave residual nevus cells, so recurrence is known after shave or radiofrequency removal. A pigmented area beside a scar may be pseudomelanoma, with melanin-laden melanocytes overlying scar tissue and no lateral spread, rather than recurrent melanoma. If the initial diagnosis is not in doubt, reexcision may not be needed; if recurrent melanoma cannot be ruled out, complete excision is required. Changing, unclear or suspicious lesions should be evaluated and, if possible, biopsied before destructive treatment. Urgent referral criteria include new or changing pigmented lesions, asymmetry, multiple colours, bleeding, itching or unclear diagnosis. The initial histology should be reviewed, and a recurrence at any time demands urgent dermatology referral.

Atypical moles are acquired lesions that can resemble melanoma; risk rises with number and family history. High-risk patients, especially with personal or family melanoma or FAMMM, should ideally be followed by a clinician experienced in melanoma diagnosis. Routine removal of all atypical moles is not recommended because most melanomas arise de novo and transformation risk for any one mole is low; removal is reserved for suspicious, changing, hard-to-monitor, special-site or dermoscopically atypical lesions. Baseline total-body photography and dermoscopy can help compare lesions over time, and monthly self-examination with a partner checking inaccessible areas is advised. Close follow-up matters most when many lesions or family history are present.

Seborrhoeic keratoses are benign epithelial tumours with sharp borders and a 'stuck on' look; dermoscopy may show milia-like cysts and comedo-like openings. Melanocytic moles are clusters of pigment cells that can sit at different skin depths, and any recent change in size or colour raises concern. Skin tags are stalked and may resemble other small growths, so surface features matter. Dermoscopy and careful clinical examination help distinguish these lesions before removal. If a lesion bleeds, grows rapidly or changes colour, malignancy must be considered and histology obtained. Removal method depends on type, size, location and anticipated depth; suspicious lesions should not be treated by destructive methods alone, because histopathological assessment may be needed.

For pigmentary lesions, correct diagnosis is of primary importance; freezing a melanoma thinking it is a hyperpigmented seborrheic keratosis can result in a fatal error. Lasers, electrosurgery, cryotherapy or other methods that physically destroy the lesion should be avoided because they do not permit histopathological examination. An excisional biopsy is preferred for a lesion concerning for melanoma to provide the most accurate diagnosis and smallest risk of recurrence. Home products may remove surface pigment without diagnosis or tissue examination, so a changing or doubtful lesion should be assessed by a qualified clinician rather than self-treated, especially when it is new, changing, atypical, or difficult to monitor.